Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Streptococcus Pneumoniae Vaccine Market Growth 2022-2028

  • LP 4913967
  • 129 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Streptococcus Pneumoniae Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Streptococcus Pneumoniae Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Streptococcus Pneumoniae Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Streptococcus Pneumoniae Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Streptococcus Pneumoniae Vaccine market, reaching US$ million by the year 2028. As for the Europe Streptococcus Pneumoniae Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Streptococcus Pneumoniae Vaccine players cover Pfizer, Sanofi, GSK, and Merck, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Streptococcus Pneumoniae Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

7 -Valent

10 -Valent

13 -Valent

15 -Valent

23 -Valent

Other

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Children under 2 Years of Age

Adults over 65 Years of Age

Addicted Smokers Between the Ages of 19 and 64

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Sanofi

GSK

Merck

Eli Lilly

AstraZeneca

Abera

S K Chemicals

Beijing Minhai Biotechnology

Baxter

Biken

Celgene Corporation

Panacea Biotec

Serum Institute of India

Genentech

Genocea Biosciences

ImmunoBiology

Lupin

Nuron Biotech

Biogen

Valneva Austria

Sinovac

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Streptococcus Pneumoniae Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Streptococcus Pneumoniae Vaccine Segment by Type

2.2.1 7 -Valent

2.2.2 10 -Valent

2.2.3 13 -Valent

2.2.4 15 -Valent

2.2.5 23 -Valent

2.2.6 Other

2.3 Streptococcus Pneumoniae Vaccine Sales by Type

2.3.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022)

2.4 Streptococcus Pneumoniae Vaccine Segment by Application

2.4.1 Children under 2 Years of Age

2.4.2 Adults over 65 Years of Age

2.4.3 Addicted Smokers Between the Ages of 19 and 64

2.4.4 Other

2.5 Streptococcus Pneumoniae Vaccine Sales by Application

2.5.1 Global Streptococcus Pneumoniae Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Streptococcus Pneumoniae Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022)

3 Global Streptococcus Pneumoniae Vaccine by Company

3.1 Global Streptococcus Pneumoniae Vaccine Breakdown Data by Company

3.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022)

3.2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Streptococcus Pneumoniae Vaccine Sale Price by Company

3.4 Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Streptococcus Pneumoniae Vaccine Product Location Distribution

3.4.2 Players Streptococcus Pneumoniae Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Streptococcus Pneumoniae Vaccine by Geographic Region

4.1 World Historic Streptococcus Pneumoniae Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Geographic Region

4.2 World Historic Streptococcus Pneumoniae Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Streptococcus Pneumoniae Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue by Country/Region

4.3 Americas Streptococcus Pneumoniae Vaccine Sales Growth

4.4 APAC Streptococcus Pneumoniae Vaccine Sales Growth

4.5 Europe Streptococcus Pneumoniae Vaccine Sales Growth

4.6 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Growth

5 Americas

5.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country

5.1.1 Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)

5.1.2 Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)

5.2 Americas Streptococcus Pneumoniae Vaccine Sales by Type

5.3 Americas Streptococcus Pneumoniae Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region

6.1.1 APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022)

6.1.2 APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022)

6.2 APAC Streptococcus Pneumoniae Vaccine Sales by Type

6.3 APAC Streptococcus Pneumoniae Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Streptococcus Pneumoniae Vaccine by Country

7.1.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)

7.1.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)

7.2 Europe Streptococcus Pneumoniae Vaccine Sales by Type

7.3 Europe Streptococcus Pneumoniae Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Streptococcus Pneumoniae Vaccine by Country

8.1.1 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type

8.3 Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine

10.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine

10.4 Industry Chain Structure of Streptococcus Pneumoniae Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Streptococcus Pneumoniae Vaccine Distributors

11.3 Streptococcus Pneumoniae Vaccine Customer

12 World Forecast Review for Streptococcus Pneumoniae Vaccine by Geographic Region

12.1 Global Streptococcus Pneumoniae Vaccine Market Size Forecast by Region

12.1.1 Global Streptococcus Pneumoniae Vaccine Forecast by Region (2023-2028)

12.1.2 Global Streptococcus Pneumoniae Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Streptococcus Pneumoniae Vaccine Forecast by Type

12.7 Global Streptococcus Pneumoniae Vaccine Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Streptococcus Pneumoniae Vaccine Product Offered

13.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Sanofi

13.2.1 Sanofi Company Information

13.2.2 Sanofi Streptococcus Pneumoniae Vaccine Product Offered

13.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sanofi Main Business Overview

13.2.5 Sanofi Latest Developments

13.3 GSK

13.3.1 GSK Company Information

13.3.2 GSK Streptococcus Pneumoniae Vaccine Product Offered

13.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GSK Main Business Overview

13.3.5 GSK Latest Developments

13.4 Merck

13.4.1 Merck Company Information

13.4.2 Merck Streptococcus Pneumoniae Vaccine Product Offered

13.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck Main Business Overview

13.4.5 Merck Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered

13.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 AstraZeneca

13.6.1 AstraZeneca Company Information

13.6.2 AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered

13.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AstraZeneca Main Business Overview

13.6.5 AstraZeneca Latest Developments

13.7 Abera

13.7.1 Abera Company Information

13.7.2 Abera Streptococcus Pneumoniae Vaccine Product Offered

13.7.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Abera Main Business Overview

13.7.5 Abera Latest Developments

13.8 S K Chemicals

13.8.1 S K Chemicals Company Information

13.8.2 S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered

13.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 S K Chemicals Main Business Overview

13.8.5 S K Chemicals Latest Developments

13.9 Beijing Minhai Biotechnology

13.9.1 Beijing Minhai Biotechnology Company Information

13.9.2 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered

13.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Beijing Minhai Biotechnology Main Business Overview

13.9.5 Beijing Minhai Biotechnology Latest Developments

13.10 Baxter

13.10.1 Baxter Company Information

13.10.2 Baxter Streptococcus Pneumoniae Vaccine Product Offered

13.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Baxter Main Business Overview

13.10.5 Baxter Latest Developments

13.11 Biken

13.11.1 Biken Company Information

13.11.2 Biken Streptococcus Pneumoniae Vaccine Product Offered

13.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Biken Main Business Overview

13.11.5 Biken Latest Developments

13.12 Celgene Corporation

13.12.1 Celgene Corporation Company Information

13.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered

13.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Celgene Corporation Main Business Overview

13.12.5 Celgene Corporation Latest Developments

13.13 Panacea Biotec

13.13.1 Panacea Biotec Company Information

13.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered

13.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Panacea Biotec Main Business Overview

13.13.5 Panacea Biotec Latest Developments

13.14 Serum Institute of India

13.14.1 Serum Institute of India Company Information

13.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered

13.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Serum Institute of India Main Business Overview

13.14.5 Serum Institute of India Latest Developments

13.15 Genentech

13.15.1 Genentech Company Information

13.15.2 Genentech Streptococcus Pneumoniae Vaccine Product Offered

13.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Genentech Main Business Overview

13.15.5 Genentech Latest Developments

13.16 Genocea Biosciences

13.16.1 Genocea Biosciences Company Information

13.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered

13.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Genocea Biosciences Main Business Overview

13.16.5 Genocea Biosciences Latest Developments

13.17 ImmunoBiology

13.17.1 ImmunoBiology Company Information

13.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered

13.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 ImmunoBiology Main Business Overview

13.17.5 ImmunoBiology Latest Developments

13.18 Lupin

13.18.1 Lupin Company Information

13.18.2 Lupin Streptococcus Pneumoniae Vaccine Product Offered

13.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Lupin Main Business Overview

13.18.5 Lupin Latest Developments

13.19 Nuron Biotech

13.19.1 Nuron Biotech Company Information

13.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered

13.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Nuron Biotech Main Business Overview

13.19.5 Nuron Biotech Latest Developments

13.20 Biogen

13.20.1 Biogen Company Information

13.20.2 Biogen Streptococcus Pneumoniae Vaccine Product Offered

13.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Biogen Main Business Overview

13.20.5 Biogen Latest Developments

13.21 Valneva Austria

13.21.1 Valneva Austria Company Information

13.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered

13.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Valneva Austria Main Business Overview

13.21.5 Valneva Austria Latest Developments

13.22 Sinovac

13.22.1 Sinovac Company Information

13.22.2 Sinovac Streptococcus Pneumoniae Vaccine Product Offered

13.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Sinovac Main Business Overview

13.22.5 Sinovac Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Streptococcus Pneumoniae Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 7 -Valent

Table 4. Major Players of 10 -Valent

Table 5. Major Players of 13 -Valent

Table 6. Major Players of 15 -Valent

Table 7. Major Players of 23 -Valent

Table 8. Major Players of Other

Table 9. Global Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 10. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 11. Global Streptococcus Pneumoniae Vaccine Revenue by Type (2017-2022) & ($ million)

Table 12. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022)

Table 13. Global Streptococcus Pneumoniae Vaccine Sale Price by Type (2017-2022) & (US$/Unit)

Table 14. Global Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 16. Global Streptococcus Pneumoniae Vaccine Revenue by Application (2017-2022)

Table 17. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2017-2022)

Table 18. Global Streptococcus Pneumoniae Vaccine Sale Price by Application (2017-2022) & (US$/Unit)

Table 19. Global Streptococcus Pneumoniae Vaccine Sales by Company (2020-2022) & (K Units)

Table 20. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Company (2020-2022)

Table 21. Global Streptococcus Pneumoniae Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company (2020-2022)

Table 23. Global Streptococcus Pneumoniae Vaccine Sale Price by Company (2020-2022) & (US$/Unit)

Table 24. Key Manufacturers Streptococcus Pneumoniae Vaccine Producing Area Distribution and Sales Area

Table 25. Players Streptococcus Pneumoniae Vaccine Products Offered

Table 26. Streptococcus Pneumoniae Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Streptococcus Pneumoniae Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Streptococcus Pneumoniae Vaccine Sales Market Share Geographic Region (2017-2022)

Table 31. Global Streptococcus Pneumoniae Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Streptococcus Pneumoniae Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Country/Region (2017-2022)

Table 35. Global Streptococcus Pneumoniae Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 38. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 39. Americas Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 41. Americas Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 42. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 43. Americas Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 44. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 45. APAC Streptococcus Pneumoniae Vaccine Sales by Region (2017-2022) & (K Units)

Table 46. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)

Table 47. APAC Streptococcus Pneumoniae Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Region (2017-2022)

Table 49. APAC Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 50. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 51. APAC Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 52. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 53. Europe Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 54. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 55. Europe Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 57. Europe Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 58. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 59. Europe Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 60. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Streptococcus Pneumoniae Vaccine

Table 70. Key Market Challenges & Risks of Streptococcus Pneumoniae Vaccine

Table 71. Key Industry Trends of Streptococcus Pneumoniae Vaccine

Table 72. Streptococcus Pneumoniae Vaccine Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Streptococcus Pneumoniae Vaccine Distributors List

Table 75. Streptococcus Pneumoniae Vaccine Customer List

Table 76. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Streptococcus Pneumoniae Vaccine Sales Market Forecast by Region

Table 78. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Streptococcus Pneumoniae Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Streptococcus Pneumoniae Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Streptococcus Pneumoniae Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Streptococcus Pneumoniae Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Streptococcus Pneumoniae Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Streptococcus Pneumoniae Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 96. Pfizer Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 97. Pfizer Streptococcus Pneumoniae Vaccine Product Offered

Table 98. Pfizer Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 99. Pfizer Main Business

Table 100. Pfizer Latest Developments

Table 101. Sanofi Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 102. Sanofi Streptococcus Pneumoniae Vaccine Product Offered

Table 103. Sanofi Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 104. Sanofi Main Business

Table 105. Sanofi Latest Developments

Table 106. GSK Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 107. GSK Streptococcus Pneumoniae Vaccine Product Offered

Table 108. GSK Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 109. GSK Main Business

Table 110. GSK Latest Developments

Table 111. Merck Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 112. Merck Streptococcus Pneumoniae Vaccine Product Offered

Table 113. Merck Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 114. Merck Main Business

Table 115. Merck Latest Developments

Table 116. Eli Lilly Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 117. Eli Lilly Streptococcus Pneumoniae Vaccine Product Offered

Table 118. Eli Lilly Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 119. Eli Lilly Main Business

Table 120. Eli Lilly Latest Developments

Table 121. AstraZeneca Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 122. AstraZeneca Streptococcus Pneumoniae Vaccine Product Offered

Table 123. AstraZeneca Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 124. AstraZeneca Main Business

Table 125. AstraZeneca Latest Developments

Table 126. Abera Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 127. Abera Streptococcus Pneumoniae Vaccine Product Offered

Table 128. Abera Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 129. Abera Main Business

Table 130. Abera Latest Developments

Table 131. S K Chemicals Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 132. S K Chemicals Streptococcus Pneumoniae Vaccine Product Offered

Table 133. S K Chemicals Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 134. S K Chemicals Main Business

Table 135. S K Chemicals Latest Developments

Table 136. Beijing Minhai Biotechnology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 137. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Offered

Table 138. Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 139. Beijing Minhai Biotechnology Main Business

Table 140. Beijing Minhai Biotechnology Latest Developments

Table 141. Baxter Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 142. Baxter Streptococcus Pneumoniae Vaccine Product Offered

Table 143. Baxter Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 144. Baxter Main Business

Table 145. Baxter Latest Developments

Table 146. Biken Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 147. Biken Streptococcus Pneumoniae Vaccine Product Offered

Table 148. Biken Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 149. Biken Main Business

Table 150. Biken Latest Developments

Table 151. Celgene Corporation Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 152. Celgene Corporation Streptococcus Pneumoniae Vaccine Product Offered

Table 153. Celgene Corporation Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 154. Celgene Corporation Main Business

Table 155. Celgene Corporation Latest Developments

Table 156. Panacea Biotec Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 157. Panacea Biotec Streptococcus Pneumoniae Vaccine Product Offered

Table 158. Panacea Biotec Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 159. Panacea Biotec Main Business

Table 160. Panacea Biotec Latest Developments

Table 161. Serum Institute of India Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 162. Serum Institute of India Streptococcus Pneumoniae Vaccine Product Offered

Table 163. Serum Institute of India Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 164. Serum Institute of India Main Business

Table 165. Serum Institute of India Latest Developments

Table 166. Genentech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 167. Genentech Streptococcus Pneumoniae Vaccine Product Offered

Table 168. Genentech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 169. Genentech Main Business

Table 170. Genentech Latest Developments

Table 171. Genocea Biosciences Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 172. Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Offered

Table 173. Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 174. Genocea Biosciences Main Business

Table 175. Genocea Biosciences Latest Developments

Table 176. ImmunoBiology Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 177. ImmunoBiology Streptococcus Pneumoniae Vaccine Product Offered

Table 178. ImmunoBiology Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 179. ImmunoBiology Main Business

Table 180. ImmunoBiology Latest Developments

Table 181. Lupin Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 182. Lupin Streptococcus Pneumoniae Vaccine Product Offered

Table 183. Lupin Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 184. Lupin Main Business

Table 185. Lupin Latest Developments

Table 186. Nuron Biotech Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 187. Nuron Biotech Streptococcus Pneumoniae Vaccine Product Offered

Table 188. Nuron Biotech Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 189. Nuron Biotech Main Business

Table 190. Nuron Biotech Latest Developments

Table 191. Biogen Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 192. Biogen Streptococcus Pneumoniae Vaccine Product Offered

Table 193. Biogen Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 194. Biogen Main Business

Table 195. Biogen Latest Developments

Table 196. Valneva Austria Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 197. Valneva Austria Streptococcus Pneumoniae Vaccine Product Offered

Table 198. Valneva Austria Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 199. Valneva Austria Main Business

Table 200. Valneva Austria Latest Developments

Table 201. Sinovac Basic Information, Streptococcus Pneumoniae Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 202. Sinovac Streptococcus Pneumoniae Vaccine Product Offered

Table 203. Sinovac Streptococcus Pneumoniae Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 204. Sinovac Main Business

Table 205. Sinovac Latest Developments

List of Figures

Figure 1. Picture of Streptococcus Pneumoniae Vaccine

Figure 2. Streptococcus Pneumoniae Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Streptococcus Pneumoniae Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Streptococcus Pneumoniae Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Streptococcus Pneumoniae Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 7 -Valent

Figure 10. Product Picture of 10 -Valent

Figure 11. Product Picture of 13 -Valent

Figure 12. Product Picture of 15 -Valent

Figure 13. Product Picture of 23 -Valent

Figure 14. Product Picture of Other

Figure 15. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type in 2021

Figure 16. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2017-2022)

Figure 17. Streptococcus Pneumoniae Vaccine Consumed in Children under 2 Years of Age

Figure 18. Global Streptococcus Pneumoniae Vaccine Market: Children under 2 Years of Age (2017-2022) & (K Units)

Figure 19. Streptococcus Pneumoniae Vaccine Consumed in Adults over 65 Years of Age

Figure 20. Global Streptococcus Pneumoniae Vaccine Market: Adults over 65 Years of Age (2017-2022) & (K Units)

Figure 21. Streptococcus Pneumoniae Vaccine Consumed in Addicted Smokers Between the Ages of 19 and 64

Figure 22. Global Streptococcus Pneumoniae Vaccine Market: Addicted Smokers Between the Ages of 19 and 64 (2017-2022) & (K Units)

Figure 23. Streptococcus Pneumoniae Vaccine Consumed in Other

Figure 24. Global Streptococcus Pneumoniae Vaccine Market: Other (2017-2022) & (K Units)

Figure 25. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2017-2022)

Figure 26. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application in 2021

Figure 27. Streptococcus Pneumoniae Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Company in 2021

Figure 29. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Geographic Region in 2021

Figure 31. Global Streptococcus Pneumoniae Vaccine Sales Market Share by Region (2017-2022)

Figure 32. Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Country/Region in 2021

Figure 33. Americas Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 34. Americas Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 35. APAC Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 36. APAC Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 37. Europe Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 38. Europe Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue 2017-2022 ($ Millions)

Figure 41. Americas Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021

Figure 42. Americas Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 43. United States Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Streptococcus Pneumoniae Vaccine Sales Market Share by Region in 2021

Figure 48. APAC Streptococcus Pneumoniae Vaccine Revenue Market Share by Regions in 2021

Figure 49. China Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021

Figure 56. Europe Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 57. Germany Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Streptococcus Pneumoniae Vaccine Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Streptococcus Pneumoniae Vaccine Revenue Market Share by Country in 2021

Figure 64. Egypt Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Streptococcus Pneumoniae Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Streptococcus Pneumoniae Vaccine in 2021

Figure 70. Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine

Figure 71. Industry Chain Structure of Streptococcus Pneumoniae Vaccine

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390